Characterization of nitric oxide generator-induced hippocampal [3H]norepinephrine release. II. The role of calcium, reverse norepinephrine transport and cyclic 3',5'-guanosine monophosphate

J Pharmacol Exp Ther. 1995 Oct;275(1):14-22.

Abstract

The mechanisms by which two nitrogen monoxide (NO) generators, hydroxylamine and S-nitroso-L-cysteine (NO-CYS), induce hippocampal [3H]norepinephrine ([3H]NE) release was investigated. Neither hydroxylamine- nor NO-CYS-induced release was affected by the guanylate cyclase inhibitors, methylene blue or LY 83,583. The effect of hydroxylamine was completely dependent on extracellular Ca++ and reduced by 40% in the presence of omega-conotoxin GVIA, an N-type Ca(++)-channel antagonist; however it was unaffected by Ni++, nifedipine, caffeine or thapsigargin. The stimulatory effect of hydroxylamine on hippocampal cyclic GMP formation was not significantly affected by removal of extracellular Ca++, indicating that Ca(++)-dependent release is not due to inhibition of NO formation from hydroxylamine. However, the response to NO-CYS was reduced by 35 to 50% in either nominally Ca(++)-free or 10 mM MgSO4-containing buffer. Interestingly, buffer containing ethylene glycol bis(beta-aminoethyl ether)-N,N'-tetraacetic acid dramatically enhanced the formation of NO from NO-CYS and potentiated the NO-CYS response. Both NO-CYS- and hydroxylamine-induced [3H]NE release was inhibited by NE transport blockers, indicating a prominent role for reverse transport. NO-CYS completely inhibited synaptosomal uptake of [3H]NE (IC50 approximately, 300 microM). NO generator-induced [3H]NE release has a glutamate-dependent component (see accompanying article). Inhibition of glutamate-evoked [3H]NE release by mazindol, an inhibitor of NE transport, suggests that the glutamate-dependent component also involves reversal of the NE transporter. These data suggest that NO produced from hydroxylamine or NO-CYS evoke both vesicular and nonvesicular release of hippocampal [3H]NE. Putative NO target molecules and the role of extracellular Ca++ are discussed.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Biological Transport, Active / drug effects
  • Biological Transport, Active / physiology
  • Calcium / physiology*
  • Cattle
  • Cyclic GMP / physiology*
  • Cysteine / analogs & derivatives*
  • Cysteine / pharmacokinetics
  • Cysteine / pharmacology
  • Hemoglobins / pharmacology
  • Hippocampus / drug effects
  • Hippocampus / metabolism*
  • Hydroxylamine
  • Hydroxylamines / pharmacokinetics
  • Hydroxylamines / pharmacology*
  • In Vitro Techniques
  • Male
  • Nitric Oxide / pharmacokinetics
  • Nitric Oxide / pharmacology*
  • Norepinephrine / metabolism*
  • Rats
  • Rats, Sprague-Dawley
  • S-Nitrosothiols*
  • Signal Transduction / physiology
  • Tritium
  • Vasodilator Agents / pharmacokinetics
  • Vasodilator Agents / pharmacology*

Substances

  • Hemoglobins
  • Hydroxylamines
  • S-Nitrosothiols
  • Vasodilator Agents
  • Tritium
  • Hydroxylamine
  • Nitric Oxide
  • S-nitrosocysteine
  • Cyclic GMP
  • Cysteine
  • Calcium
  • Norepinephrine